Featured Articles
Trending Articles
Nipocalimab Submitted to FDA for Treatment of Generalized Myasthenia Gravis
FDA & EMA | 30 August 2024
First Lung Cancer Vaccine Trial for BioNTech's BNT116 Launched Across 7 Countries
ONCOLife | 25 August 2024
Next-Generation Weight Loss Therapeutic Nimacimab Enters Phase 2 Clinical Trial
Clinical Trials | 22 August 2024
Novel Cancer Drug PT217 Wins FDA Orphan Drug Status for Neuroendocrine Carcinoma
FDA & EMA | 20 August 2024
Lung Cancer Treatment for Never Smokers: The HARMONIC Phase 2 Trial and LP-300
ONCOLife | 19 August 2024
AI-Powered Treatment Success: LP-300 Shows Promise for Non-Smoker Lung Cancer
ONCOLife | 12 August 2024
Merck Ends KeyVibe-008 Trial Over Safety Concerns: A Setback in Lung Cancer
ONCOLife | 9 August 2024
The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan
Pharma | 9 August 2024
Novel Immunotherapy IMNN-001 Shows Extended Survival Rates for Ovarian Cancer
ONCOLife
3 August 2024
FDA Approves Expanded Use of Dostarlimab for Treatment of Endometrial Cancers
FDA & EMA
2 August 2024
Novel Cell Therapy Tecelra Receives FDA Accelerated Approval for Synovial Sarcoma
ONCOLife
2 August 2024
FDA Approves Johnson's Daratumumab Plus VRd for Newly Diagnosed Multiple Myeloma
FDA & EMA
30 July 2024
FDA Approves First Blood Test for Early Detection and Screening of Colorectal Cancer
ONCOLife
31 July 2024
Beyond Chemotherapy: The Rise of Precision Medicine and Targeted Therapy with ADCs
ONCOLife
22 July 2024
SenoVax: Targeting "Zombie Cells" to Destroy Tumor Barriers and Combat Lung Cancer
ONCOLife
26 July 2024
FDA Clears ZW191 for Clinical Trials: Novel Drug Targets NSCLC and Ovarian Cancer
FDA & EMA
24 July 2024
Darolutamide Shows Promise in Phase III ARANOTE Trial for Treating Prostate Cancer
ONCOLife
19 July 2024